Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
מצבים רפואיים
Ovarian Cancer · Pancreas Cancer · Urothelial Carcinoma · Renal Cell Carcinoma · Hepatocellular Carcinoma · Gastrointestinal Cancer · Lung Cancer · Prostate Cancer · Breast Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Southern California, Los Angeles, California, United States
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles, California, United States
Cedars-Sanai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Alain Mita, MD)Hoag Memorial Hospital Presbyterian, Newport, California, United States
Sarah Cannon Research Institute - Denver DDU, Denver, Colorado, United States
Emory University - Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Study coordinator (Fatemeh Ardeshir, MD) · fatemeh.ardeshir.larijani@emory.edu · 404-778-0202New York Cancer & Blood Specialists, New York, New York, United States
University of Rochester - Wilmot Cancer Institute, Rochester, New York, United States
START San Antonio, San Antonio, Texas, United States
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Binod Dhakal, MD)
מובילי המחקר
Dennis Kim, MD
Study Director
Nammi Therapeutics Inc